| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.4549 | 15 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.9476 | 41 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.3172 | 49 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.1876 | 38 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.3739 | 46 |
| GSM780721 | Untreated after 4 days (C3_2) | 59.1801 | 64 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.2245 | 49 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.7316 | 16 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.8502 | 44 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 52.5549 | 55 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.5393 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.7354 | 36 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.7136 | 31 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.9555 | 32 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.4501 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.6569 | 57 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.3492 | 38 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.6528 | 50 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.8327 | 17 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.8077 | 48 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.161 | 33 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 56.5376 | 61 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.0541 | 54 |